Early Access

10-KPeriod: FY2024

UNITEDHEALTH GROUP INC Annual Report, Year Ended Dec 31, 2024

Filed February 27, 2025For Securities:UNH

Summary

UnitedHealth Group Inc. (UNH) presented a solid financial performance for the year ended December 31, 2024, marked by an 8% increase in total revenues to $400.3 billion. This growth was primarily driven by strong performance in its Optum segment, particularly Optum Rx and Optum Health, which saw revenue increases of 15% and 11% respectively, alongside a 6% rise in UnitedHealthcare's revenue. Despite a reported net loss of $7.98 billion on a diluted EPS basis (or $15.51 per share) due to a significant loss on the sale of its Brazil operations and other South American businesses ($8.3 billion), the company demonstrated operational resilience. Key operational highlights include serving a larger member base through UnitedHealthcare's domestic offerings, with a 5% increase in total individuals served. The company also managed the significant impact of the Change Healthcare cyberattack, incurring $2.2 billion in direct response costs and an estimated $867 million in business disruption impacts for Optum Insight, while providing over $9 billion in interest-free loans to care providers. Management remains focused on navigating medical cost trends, government funding pressures in Medicare Advantage, and ongoing investments in value-based care models and technology, positioning the company for continued strategic growth.

Financial Statements
Beta
Revenue$400.28B
Cost of Revenue$46.69B
Gross Profit$353.58B
SG&A Expenses$53.01B
Operating Expenses$367.99B
Operating Income$32.29B
Interest Expense$3.91B
Net Income$14.40B
EPS (Basic)$15.64
EPS (Diluted)$15.51
Shares Outstanding (Basic)921.00M
Shares Outstanding (Diluted)929.00M

Key Highlights

  • 1Total revenues increased by 8% to $400.3 billion, driven by strong growth across Optum Rx (+15%) and Optum Health (+11%), and UnitedHealthcare (+6%).
  • 2Despite a reported net loss of $7.98 billion (EPS of $15.51), primarily due to the sale of South American operations, operational earnings remained stable at $32.3 billion.
  • 3UnitedHealthcare saw an increase of 2.1 million individuals served domestically, reflecting growth in commercial offerings, though partially offset by Medicaid redeterminations.
  • 4The company incurred $2.2 billion in direct response costs and $867 million in business disruption impacts from the Change Healthcare cyberattack, while providing $9 billion in interest-free loans to care providers.
  • 5Optum Health served approximately 100 million people, with revenue growth driven by value-based care arrangements.
  • 6The company continues to invest in value-based care models and advanced analytics and technology, crucial for its long-term strategy.
  • 7Dividend per share increased to an annual rate of $8.40, and the company repurchased $9 billion in common stock during the year.

Frequently Asked Questions